Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial (2018)
- Authors:
- Autor USP: DALL'OGLIO, MARCOS FRANCISCO - FM
- Unidade: FM
- DOI: 10.1016/j.eururo.2017.06.021
- Subjects: NEOPLASIAS PROSTÁTICAS; METÁSTASE NEOPLÁSICA; RADIOTERAPIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European urology
- ISSN: 0302-2838
- Volume/Número/Paginação/Ano: v. 73, n. 3, p. 427-435, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PARKER, Christopher C. e DALL'OGLIO, Marcos Francisco. Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial. European urology, v. 73, n. 3, p. 427-435, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.eururo.2017.06.021. Acesso em: 27 fev. 2026. -
APA
Parker, C. C., & Dall'Oglio, M. F. (2018). Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial. European urology, 73( 3), 427-435. doi:10.1016/j.eururo.2017.06.021 -
NLM
Parker CC, Dall'Oglio MF. Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial [Internet]. European urology. 2018 ; 73( 3): 427-435.[citado 2026 fev. 27 ] Available from: https://doi.org/10.1016/j.eururo.2017.06.021 -
Vancouver
Parker CC, Dall'Oglio MF. Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial [Internet]. European urology. 2018 ; 73( 3): 427-435.[citado 2026 fev. 27 ] Available from: https://doi.org/10.1016/j.eururo.2017.06.021 - Doenças da próstata
- Doenças da próstata
- Does the Presence of Median Lobe Affect Outcomes of Robot-Assisted Laparoscopic Radical Prostatectomy?
- Estudo de genes diferencialmente expressos no carcinoma de células claras do rim pela técnica de microarray
- Predicting outcomes in partial nephrectomy: is the renal score useful?
- Novidades diagnósticas, estratégias cirúrgicas e biologia molecular serão temas do III Simpósio Internacional de Câncer Urológico
- PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples
- Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer
- Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy?
- Robotic-assisted laparoscopic partial nephrectomy: initial experience in Brazil and a review of the literature
Informações sobre o DOI: 10.1016/j.eururo.2017.06.021 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
